About Suhasa Kodandaramaiah
Form D filings for Objective Biotechnology in 2024 list Suhasa Kodandaramaiah as executive officer and director.
Suhasa Kodandaramaiah first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Suhasa Kodandaramaiah in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Suhasa Kodandaramaiah works with at each company, as listed on that company's latest Form D.
Objective Biotechnology, Inc. · Form D, Nov 26, 2024
JG
James Grabau
CEO
DS
Daniel Surinach
Executive officer and director
AJ
Amey Joshi
Executive officer and director
AA
Andrew Alegria
Executive officer and director
DG
Daryl Gohl
Executive officer and director